MetrioPharm AG

Industry / private company


Location: Zurich, Switzerland (CH) CH

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Novel, orally available immune modulator MP1032 with pan-variant anti-SARS-CoV-2 and anti-inflammatory activity (2022) Schumann S, Setz C, Schulz P, Kaiser A, Schubert U, Brysch W Conference contribution Immune‐modulating drug MP1032 with SARS‐CoV‐2 antiviral activity in vitro: A potential multi‐target approach for prevention and early intervention treatment of COVID‐19 (2020) Schumann S, Kaiser A, Nicoletti F, Mangano K, Fagone P, van Wijk E, Yan Y, et al. Journal article